| Symbol | ACET |
|---|---|
| Name | ADICET BIO, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 200 CLARENDON STREET,FLOOR 6, BOSTON, Massachusetts, 02116, United States |
| Telephone | +1 650 503-9095 |
| Fax | — |
| — | |
| Website | https://www.adicetbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001720580 |
| Description | Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Additional info from NASDAQ: |
Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
Read more(30% Negative) ADICET BIO, INC. (ACET) Announces Delay in development Trials for ADI-212 in mCRPC Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreAdicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update
Read moreKlickstein Lloyd 🟢 acquired 18.3K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $9.16 Transaction Date: Aug 05, 2026 | Filing ID: 000003
Read moreAdicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
Read moreAdicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference
Read moreSchor Chen 🟢 acquired 55.0K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 19, 2026 | Filing ID: 000007
Read moreAftab Blake 🟢 acquired 55.0K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 19, 2026 | Filing ID: 000004
Read more